A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study.
about
Chemotherapy-and cancer-related nausea and vomitingTreatment of Breakthrough and Refractory Chemotherapy-Induced Nausea and VomitingChemotherapy-induced nausea and vomiting: optimizing prevention and managementEvolving treatment paradigms for chemotherapy-induced nausea and vomitingReview of palonosetron: emerging data distinguishing it as a novel 5-HT(3) receptor antagonist for chemotherapy-induced nausea and vomiting.Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogeneticsOlanzapine: an antiemetic option for chemotherapy-induced nausea and vomitingUpdate and new trends in antiemetic therapy: the continuing need for novel therapies.Palonosetron in the management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day chemotherapy.Management of chemotherapy-induced nausea and vomiting : focus on newer agents and new uses for older agents.Use of granisetron transdermal system in the prevention of chemotherapy-induced nausea and vomiting: a reviewPrevention of acute chemotherapy-induced nausea and vomiting: the role of palonosetron.Palonosetron for the prevention of chemotherapy-induced nausea and vomiting: approval and efficacy.The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy.Palliative care in BMT.Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain.Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients.Palonosetron: a second generation 5-hydroxytryptamine 3 receptor antagonist.Palonosetron hydrochloride for the prevention of chemotherapy-induced nausea and vomiting.Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients with cancer.Olanzapine: palliative medicine update.Olanzapine for chemotherapy-induced nausea and vomiting: a systematic review.Comparative effectiveness research in antineoplastic-induced nausea and vomiting control in children.Meta-analysis of adjunctive non-NK1 receptor antagonist medications for the control of acute and delayed chemotherapy-induced nausea and vomiting.The safety of olanzapine in young children: a systematic review and meta-analysis.Palonosetron for the treatment of chemotherapy-induced nausea and vomiting.Olanzapine for treatment and prevention of acute chemotherapy-induced vomiting in children: a retrospective, multi-center review.Efficacy and safety of olanzapine for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) as reported in phase I and II studies: a systematic review.Feasibility of olanzapine, multi acting receptor targeted antipsychotic agent, for the prevention of emesis caused by continuous cisplatin- or ifosfamide-based chemotherapy.State of the Art Antiemetic Therapy for Cancer Patients.The safety of antiemetic medications for the prevention of chemotherapy-induced nausea and vomiting.Efficacy of olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis.Emerging Role of Olanzapine for Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting.Central Aspects of Nausea and Vomiting in GI Disorders.Antiemetic therapy for non-anthracycline and cyclophosphamide moderately emetogenic chemotherapy.Antiemetic research: future directions.Management of chemotherapy-induced nausea and vomiting.Effectiveness of olanzapine in patients who fail therapy with aprepitant while receiving highly emetogenic chemotherapy.Role of olanzapine in chemotherapy-induced nausea and vomiting on platinum-based chemotherapy patients: a randomized controlled study.A double-blind randomized phase II dose-finding study of olanzapine 10 mg or 5 mg for the prophylaxis of emesis induced by highly emetogenic cisplatin-based chemotherapy.
P2860
Q24644831-D36C86A2-010A-459D-AE1D-3FD7D326DCC7Q26784070-54F7AF6E-AB20-41C9-AA81-D685DAA389CCQ26852601-FCBCB706-B0AD-4AE3-9C6B-9CC6A7F92BD2Q27024463-8437931B-74BE-4D0C-A0F1-2FB7938856D9Q33543954-37A1E629-53DC-4DFB-8EEA-5FCAFB84E116Q33834310-7CA499C7-51F5-435B-815A-14D897FF96E3Q33886138-933AF60E-97CC-4750-B84F-BE7661A64B2FQ34143667-452A1B9A-BB50-47F7-9152-11E4287F8754Q34166946-FAF240AE-F180-4628-A34A-74203E4CF3E2Q34327488-7D5355B8-79F6-4191-A1F6-981E220DB602Q34417851-51E2C448-0699-41DA-8A3C-DFA54E9D2EA7Q34418451-E590FD52-706E-446D-A158-DB18B44F85EEQ34418467-F6E7B08E-6D7C-4427-A8B8-EFD2AB66E366Q34647257-E271A067-B5A1-4B7D-985C-EE2500082D87Q34924467-B3653893-9613-4B73-8724-DC0BFACC97B9Q37038999-822409AF-C702-4A03-B9E6-0018308F47D1Q37609798-89F50AB4-82E5-4ED7-BEEB-2C5410BB8929Q37636028-1D7385C7-E31C-4ACD-9F6C-1604EA419668Q37687368-5589A440-44FE-41B3-A5A9-259D9D88CB75Q37771953-73E4DD95-B8B9-4891-8EB0-B85DE20BCD7DQ38001959-6380F176-AE79-4548-9B81-D5FE5FDD2809Q38187578-F209F2E5-19AB-4824-8DA8-10539A771DB1Q38197218-FF9412CC-83CA-4D46-A1ED-2BC37EED02EBQ38241998-F4A610A9-F2CB-423C-99BE-7FBBDDED31ACQ38242011-6E1E681E-9EB6-4D61-A630-56124F283A06Q38260952-27DCA7B7-AA29-42E2-97A4-BEA3D1065EEFQ38261290-6A8BD862-AFE9-4ECE-89ED-DD523F65965EQ38623597-5D637084-AFB8-47B7-883C-F87CCF703C1DQ38653463-2073F768-CEC2-4EC3-9220-358AAD3807C1Q38676452-0A78FC67-E0F7-44B7-9FC6-1E6C8A65683DQ38677762-A90E0C0C-5259-45A2-8DBC-F13E65D357BFQ38696953-F75AB598-8CF8-4AFC-B6B5-0701031FDF3AQ38739169-F4BCD282-BB94-4E31-A69E-B6C1CAC35018Q38979261-17F1A28F-47BE-4D58-AE72-D88E9FD58467Q39213490-3B5C70C6-19D2-43B8-A2B9-E7A8E9784214Q39818791-9CF34EDB-6EE6-4DBE-AE5A-3E6831BC25CDQ42786722-E2725DAD-CF29-456F-AF7C-E20F7E78A1D6Q47296270-38870240-74FE-48A7-B1C0-EA207DFA79A0Q47664267-12198215-2610-4C2E-9773-ACAC0A148E24Q47741649-5BAAF449-1A9D-4251-A6BC-96FE45029B44
P2860
A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
A phase II trial of olanzapine ...... Hoosier oncology group study.
@ast
A phase II trial of olanzapine ...... Hoosier oncology group study.
@en
A phase II trial of olanzapine ...... Hoosier oncology group study.
@nl
type
label
A phase II trial of olanzapine ...... Hoosier oncology group study.
@ast
A phase II trial of olanzapine ...... Hoosier oncology group study.
@en
A phase II trial of olanzapine ...... Hoosier oncology group study.
@nl
prefLabel
A phase II trial of olanzapine ...... Hoosier oncology group study.
@ast
A phase II trial of olanzapine ...... Hoosier oncology group study.
@en
A phase II trial of olanzapine ...... Hoosier oncology group study.
@nl
P2093
P921
P1476
A phase II trial of olanzapine ...... Hoosier oncology group study.
@en
P2093
Cynthia S Johnson
Jake Vinson
John McClean
Lawrence H Einhorn
Nasser H Hanna
Naveed Chowhan
Patrick J Loehrer
Rudolph M Navari
Steven D Passik
P2888
P304
P356
10.1007/S00520-007-0248-5
P577
2007-03-21T00:00:00Z